Fact CheckerSign in

NCT06887504Completed

The Evaluation of White Matter Intensities in Patients with Pediatric Epilepsy

Source: ClinicalTrials.gov · Last updated 20 Mar 2025

Brief summary (registry, in English)

Aim: Neuroimaging is an important tool, in combination with a detailed medical history, physical examination, and electroencephalography, in the diagnosis and classification of epilepsy. White matter hyperintensities (WMHs) are bright areas of high signal intensity seen in white matter at T2-weighted MRI. Researchers aimed to evaluate whether white matter hyperintensities are more common in children with epilepsy. Material-method: Patients who underwent cranial MRI with diagnoses of epilepsy based on International League Against Epilepsy (ILAE) criteria at the Balıkesir University Medical Faculty Pediatric neurology clinic, Türkiye, between 01.08.2019 and 01.03.2024 and patients who underwent cranial MRI during the same period due to indications other than epilepsy, such as headache, syncope, and vertigo, were included in the study. Written informed consent was received from all patients.

Status (registry)
Completed
Study type
Observational
Enrollment
173 (actual)
First submitted
17 Feb 2025
Start date
1 Aug 2019
Primary completion date
1 Mar 2024
Lead sponsor
Aysen Orman
Diseases
Epilepsy
NCT number
NCT06887504

What you commit to

  • Study type: Observational
  • Participants enrolled: 173
  • From 1 Aug 2019 to the primary completion date, 1 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with neuropsychiatric disorders;
  • psychotic disorders,
  • autism spectrum disorder History of medication use for any chronic disease other than seizure medication, History of vascular disease ;
  • Collagen tissue diseases;
  • Kawasaki disease Demyelinating disease
  • acute demyelinating disease (ADEM),
  • Multiple sclerosis Acute symptomatic seizure or a single unprovoked seizure, İncomplete file data, or MRI performed at a location other than our hospital

Other

  • depression,
  • lupus,
  • juvenile rheumatoid arthritis,
  • polyarteritis nodosa,

Who the study is looking for

  • Cranial MRI during the same period due to indications other than epilepsy;
  • headache
  • syncope and
  • vertigo

Age in the registry: 5 years to 16 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mersin University
Coordinator of this site? Confirm its status
MersinTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.